Background {#Sec1}
==========

*Capnocytophaga canimorsus* is a gram-negative bacillus found in saliva of healthy dogs and cats and is transmitted to humans principally through animal bites \[[@CR1]\]. It can cause sepsis and other forms of infection. Here, we report a patient with sepsis and infective endocarditis (IE) caused by *C. canimorsus*. As *C. canimorsus* IE is rare and this microbe is difficult to culture, drug susceptibility is often unclear and its standard treatment regimen remains unestablished.

Case presentation {#Sec2}
=================

A 46-year-old man with a history of dog-bite in his left hand 3 months ago, developed fever (body temperature \> 38 °C), visual disturbance, and dyspnea at rest. He had been otherwise healthy without significant medical history. He was tachycardic, and coarse crackle and diastolic heart murmur (Levine III) was audible. Laboratory test results were as follows: white blood cell count, 10,500/μL (59.8% neutrophils); hemoglobin level, 11.7 g/dL; brain natriuretic protein level, 689.2 pg/mL; and C-reactive protein level, 9.0 mg/dL (Table [1](#Tab1){ref-type="table"}). Chest X ray showed pulmonary congestion and bilateral pleural effusion. Brain magnetic resonance imaging revealed no lesion in optic nerve and brain. Transthoracic echocardiography revealed moderate-to-severe aortic valve regurgitation and vegetation of 17-mm in size (Fig. [1](#Fig1){ref-type="fig"}). Seven days later, blood culture yielded *Coagulase-negative staphylococci* in one of four culture bottles. Although diagnosis of IE was not definitive according to Duke criteria \[[@CR2]\], history of dog bites, his clinical course, and imaging studies suggested *Staphylococcal* IE. Following administration of cefazolin 6 g/day and gentamycin 3 mg/kg/day for a week, the patient underwent aortic valve replacement and resected aortic valve was negative for Staphylococci. A week following surgery, however, microorganism grew in two bottles of preoperative blood culture. This microorganism was cultured on blood agar, and gram staining of the colonies showed *Capnocytophaga-*like gram-negative bacilli (Fig. [2](#Fig2){ref-type="fig"}). 16S ribosome DNA sequencing both from blood and from resected heart valve identified *C. canimorsus*. Disk diffusion test revealed that the isolate was susceptible to almost all antimicrobial agents and did not produce β-lactamase (Table [2](#Tab2){ref-type="table"}). The protocol of the disk diffusion test was as follows: A Brucella HK agar plate was seeded with a lawn of *C. canimorsus* using sterile cotton swabs. For the plate, antibiotic disks containing 10 IU of penicillin G, 10 μg/10 μg of sulbactam/ampicillin, 10 μg/100 μg of tazobactam/piperacillin, 30 μg of ceftriaxone, 10 μg of meropenem, 10 μg of gentamycin, 30 μg of amikacin, 5 μg of levofloxacin, 30 μg of minocycline, 250 μg of sulfamethoxazole/trimethoprim, 15 μg of clarithromycin, 2 μg of clindamycin were used with BD Sensi-Disc (BD Bioscience Co., USA) and dispensed on the agar surface. Both plates were incubated at 30 °C overnight and the diameter of each zone was measured in millimeters to evaluate susceptibility or resistance using the comparative standard method. Table 1Laboratory data on admission(A) Peripheal blood dataPeripheral Blood WBC10,500 /μL Neut59.8% Lymp31.1% Mono4.9% Eosi3.9% Baso0.3% RBC430 × 10^6^/μL HCT42.0% Hb11.7 g/dL MCV97.7 fL MCH32.3 pg MCHC33.1 pg PLT22.4 × 10^6^/μL(B) Chemistry dataChemistry TP6.3 g/dL ALB4.0 g/dL AST126 IU/L ALT101 IU/L LDH179 IU/L γGTP24 U/L BUN15 mg/dL Cr0.71 mg/dL Na142 mEq/L K3.3 mEq/L Cl107 mEq/L CRP9.0 mg/dL BNP689.2 pg/mL*WBC* white blood cells, *Neut* neutrophils, *Lymp* lymphocytes, *Mono* monocytes, *Eosi* eosinophils, *Baso* basophils, *RBC* red blood cells, *HCT* hematocrit, *Hb* hemoglobin, *MCV* mean cell volume, *MCH* mean corpuscular hemoglobin, *MCHC* mean corpuscular hemoglobin concentration, *PLT* platelet counts, *TP* total protein, *ALB* albumin, *AST* aspartate aminotransferase, *ALT* alanine aminotransferase, *LDH* lactate dehydrogenase (upper limited: 211 IU/L), *γ-GTP* γ-glutamyl transpeptidase, *BUN* blood urea nitrogen, *Cr* creatinine, *Na* sodium, *K* potassium, *Cl* chlorine, *CRP* C-reaction peptide, *BNP* brain natriuretic protein Fig. 1Echocardiogram showing moderate-to-severe aortic valve regurgitation and vegetation of 17-mm in size Fig. 2*Capnocytophaga-*like gram-negative bacilli on the aortic valve (× 1000) Table 2Drug susceptibility shown by disk diffusion methodAntimicrobial AgentsInhibition Zone (mm)Penicillin G32Sulbactam/Ampicillin36Tazobactam/Piperacillin38Ceftriaxone20Meropenem36Gentamycin\<  6Amikacin\<  6Levofloxacin34Minocycline40Sulfamethoxazole/Trimethoprim\<  6Clarithromycin38Clindamycin34

Based on these results and symptoms, empirically selected combination of gentamycin and cefazolin was converted to ceftriaxone 4 g/day. The patient completed a total of 4 weeks of ceftriaxone. The patient has been doing well for 12 months after hospital discharge.

Discussion and conclusion {#Sec3}
=========================

*C. canimorsus* is a less virulent pathogen. IE accounts for less than 2% of *C. canimorsus* bloodstream infection and is extremely rare \[[@CR3]\]. Only 18 cases have been reported in the literatures since 1977 (Table [3](#Tab3){ref-type="table"}) \[[@CR4]--[@CR10]\]. Patients were 52.8 years of age (range 24 to 73 years) on average and were predominantly male (80.0%). Affected valves were aortic in 11 (61.1%), tricuspid in six (33.3%), and mitral in four (22.2%). Nine patients (50.0%) were surgically treated, mostly using mechanical valves. Penicillin was given in eight (44.4%), and Cephalosporin in four (22.2%). Four patients (22.2%) had underlying cardiac diseases, and five (27.7%) were vulnerable to infection; alcohol abuse in four and chronic lymphocytic leukemia undergoing chemotherapy in one. Twelve of 18 patients (66.6%) had dog bite or close contact with dogs. Table 3Infective endocarditis caused by *Capnocytophaga canimorsus* in literatureNoAge/SexAnimal contactUnderlying diseaseInfected valveSurgery (Methods)AntibioticsComplicationsOutcomeReferences1NDDogNDAYes (ND)NDNDD\[[@CR4]\]2NDNDNDANoNDNDS3NDNDNDMNoNDNDS464/MDogNDT, ANoPenicillin + ErythromycinNDD559/FNDCLL, Atrial myxoma, Steroid useTYes (ND)Cephalothin + GentamicinNDD639/MDogAlcohol abuseMNoAmpicillin + TobramycinGlomerulonephritis.S724/MDogNoneANoPenicillinNDS847/MDogAlcohol abuseTYes (ND)Vancomycin + GentamicinNDS956/MDogNoneTNoPenicillin + GentamicinNDS1052/MDogNoneANoPenicillin + AztreonamNDS1169/FNoneCOPDTNoPenicillinCHFS1263/MDogAVR (Mechanical valve)A (Periannular abscess)Yes (AVR, Tissue valve)PenicillinAnemia, CHFS1341/FDogRheumatic mitral valve diseaseMYes (MVR, Mechanical valve)CeftriaxoneNDS\[[@CR5]\]1442/MDogAlcohol abuseAYes (AVR, Mechanical valve)Ceftriaxon + GentamicinNDS\[[@CR6]\]1555/MDogCOPD, Alcohol abuse, Intravenous drug userA (Periannular abscess), TYes (AVR, Mechanical valve), (Aortoplasty) (Tricuspid valve repair)Meropenem+ CiprofloxacinNDS\[[@CR7]\]1665/MNoneDislipidemiaA (Periannular abscess)Yes (Aortic root replacement, Mechanical valve)Ampicillin + GentamicinAnemia, Renal insufficiencyS\[[@CR8]\]1773/MDogAVR (Mechanical valve), Diabetes, Renal insufficiencyANoMeropenem + CiprofloxacinAnemiaS\[[@CR9]\]1843/MLionNoneA, MYes (AVR, Mechanical valve) (Mitral valve annuloplasty), (Coronary artery bypass grafting)Ceftriaxone + Gentamicin + VancomycinNoneS\[[@CR10]\]*ND* No Data, *M* Male, *F* Female, *CLL* Chronic Lymphocytic Lymphoma, *COPD* Chronic Obstructive Pulmonary Disease, *AVR* Aortic valve replacement, *A* Aortic valve, *M* Mitral valve, *T* Tricuspid valve, *MVR* Mitral valve replacement, *CHF* Congestive heart failure, *D* Died, *S* Survived

*C. canimorsus* is a facultative anaerobe and grows slowly in blood culture bottles and on agar plates. It has fastidious requirements for growth (5-10% CO~2~) and efficient culture method has not yet been established. Diagnosis of *C. canimorsus* IE generally requires high indices of suspicion because clinical symptoms are non-specific and routine blood cultures are often negative. If a pet owner or an immunocompromised host develops IE and blood culture is initially negative, therefore, longer incubation or terminal subculture should be considered. In addition, Polymerase chain reaction and sequencing for 16S rDNA is useful to identify *C. canimorsus* \[[@CR11], [@CR12]\].

Since IE is a life threatening illness, antibiotic treatment often needs to be commenced before causative organism is identified. Aminoglycosides and/or β-lactam antibiotics are common empirical drugs of choice. However, almost all strains of *C. canimorsus* are resistant to aminoglycosides \[[@CR13]\]. Decades ago, β-lactamase-producing *Capnocytophaga* was less than 2% \[[@CR14]\], but recent papers suggest such strains have remarkably increased and account for 32% \[[@CR15]\] or 79% \[[@CR16]\]. So far, prognosis of *C. canimorsus* IE is poor chiefly due to delay in diagnosis and suboptimal drug choice. During treatment for *C. canimorsus* IE, therefore, addition of β-lactamase-inhibitor might be beneficial. In the present case, we chose Ceftriaxone soon after extended culture yielded gram negative bacilli. As disk diffusion test showed the strain was sensitive to β-lactam antibiotics, Ceftriaxone was continued until completion.

In conclusion, *C. canimorsus* is a fastidious and slow-growing microbe. *C. canimorsus* IE shows no specific findings but this pathogen should be kept in mind especially when pet owners show fever of unknown origin. Longer incubation along with some molecular biological diagnostic methods should be considered. Because diagnosis of *C. canimorsus* IE is often delayed and β-lactam tolerance is relatively common, its prognosis is not good. Prompt antimicrobial susceptibility test is essential.
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